The provider report
Kin Meds sermorelin review
Thirty-day and ninety-day supply options are presented without an established public price. The page says there is no automatic subscription and includes shipping and supplies. It also says treatment is not charged if a provider decides prescribing is inappropriate.
Before you pay
- Formulation
- troche
- Published medication details
- Not specified
- Billing arrangement
- Quote needed
On this page
Pricing and billing terms
Kin Meds's published information does not give us a price with a clear billing basis. Ask for a written quote covering the medication, consultation, labs and renewal terms before comparing it with a subscription.
The public information checked in October 2026 does not establish a comparable treatment price. Ask for the initial payment, recurring charges and included medication quantity together.
Thirty-day and ninety-day supply options are presented without an established public price. The page says there is no automatic subscription and includes shipping and supplies. It also says treatment is not charged if a provider decides prescribing is inappropriate.
Before comparing an unspecified supply, understand vial strength, quantity and prescribed dose. For introductory or incomplete quotes, consider the costs a headline price may leave out. Once you have both written offers, use the quote comparison calculator.
What is published
- State availabilityNot currently available in California
- Formulationtroche
What to confirm
- Treatment costRequest a written quote covering the medication, care fees and future orders.
- Medication quantityAsk how much medication the quoted price includes.
- Included servicesConfirm consultation, laboratory, shipping and supply charges.
- Dispensing pharmacyRequest the pharmacy’s name and contact details before ordering.
Care, enrollment and cancellation
Kin Meds describes an online licensed-provider review for compounded troches, with optional laboratory testing and ongoing care-team messaging. The product page excludes California. It does not establish the numerical troche strength or a named dispensing pharmacy.
Before your first payment, review cancellation and refund terms. For assessment and testing charges, see what to ask before paying for blood tests.
Pharmacy and availability
- Published medication details
- Not stated in the information reviewed. Ask what quantity your prescription includes.
- Formulations
- troche
- State availability
- Not currently available in California
- Insurance, HSA and FSA
- HSA/FSA eligible
- Dispensing pharmacy
- No dispensing pharmacy confirmed for this product. Request its name and contact details before ordering.
Formulations and prescribed quantities can differ between providers. An oral product, an injection and a nasal spray should not be assumed interchangeable. Review the evidence on non-injectable forms and discuss the specific product with your clinician.
To identify the pharmacy behind a prescription, review what to check about the compounder. Confirm product-specific availability using our guide to state and shipping restrictions.
Pricing transparency
Kin Meds scores 10 out of 100 on published pricing information. This measures disclosure of price, supply, inclusions and availability. It is not a rating of medical care, safety or treatment effectiveness.
The disclosure score follows our published review methodology.
Scroll the table sideways for the remaining columns.
| What is scored | Earned | Out of | What the page shows |
|---|---|---|---|
| What kind of figure it publishes | 0 | 40 | no figure we could qualify as a price |
| States the billing cycle | 0 | 15 | no cycle stated |
| States how much drug the price buys | 0 | 15 | nothing about dose on the page we read |
| Itemizes what the price includes | 0 | 10 | nothing itemized beside the figure |
| Names a pharmacy on a sermorelin page | 0 | 10 | no compounder named on any sermorelin page we read |
| States the states it serves | 5 | 5 | Not currently available in California |
| Leaves no unlabeled figure on the page | 5 | 5 | every figure on the page carries what it is |
| Total | 10 | 100 | Higher means more pricing information is available publicly. |
The score summarizes published pricing details. It does not measure clinical quality, safety or treatment effectiveness.